FACTOR VII-PHOSPHOLIPID COMPLEX IN MALE SURVIVIRS OF ACUTE MYCORDIAL INFARCTION
暂无分享,去创建一个
P Smith | H. Prydz | H. Arnesen | H Prydz | K Dalaker | H Arnesen | Pål J. Smith | P. Smith | K. Dalaker
[1] I. Holme,et al. The Oslo study. Cardiovascular disease in middle-aged and young Oslo men. , 1975, Acta medica Scandinavica. Supplementum.
[2] M S Golden,et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. , 1980, The New England journal of medicine.
[3] H. Prydz,et al. Phospholipase C from Bacillus cereus has sphingomyelinase activity. , 1982, Scandinavian journal of clinical and laboratory investigation.
[4] C. Little,et al. Purification by affinity chromatography of phospholipase C from Bacillus cereus , 1975, FEBS letters.
[5] W. Kannel,et al. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. , 1979, Annals of internal medicine.
[6] C. Little,et al. A simple purification scheme yielding crystalline phospholipase C from Bacillus cereus. , 1980, Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry.
[7] T. Meade,et al. HYPERTRIGLYCERIDAEMIA AND HYPERCOAGULABILITY , 1983, The Lancet.
[8] N. Söderström. How to use cytodiagnostic spleen puncture. , 2009, Acta medica Scandinavica.
[9] P. Rentrop,et al. Selective Intracoronary Thrombolysis in Acute Myocardial Infarction and Unstable Angina Pectoris , 1981, Circulation.
[10] S. Kjeldsen,et al. Blood platelet release correlates with serum lipids in 50 year old men with essential hypertension. , 2009, Acta medica Scandinavica. Supplementum.
[11] S. Koskinen,et al. Association of serum lipids and obesity with cardiovascular mortality. , 1977, British medical journal.
[12] R. Clara,et al. LEVAMISOLE AND AGRANULOCYTOSIS , 1977, The Lancet.
[13] S. Isomura,et al. CONTACT INFECTION FROM LIVE VARICELLA VACCINE RECIPIENTS , 1976, The Lancet.
[14] C. Bengtsson,et al. Triglycerides--main lipid risk factor for cardiovascular disease in women? , 2009, Acta medica Scandinavica.
[15] H. Prydz,et al. A new form of coagulation factor VII in plasma. , 2009, Scandinavian Journal of Haematology.
[16] R. Bawol,et al. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. , 1980, The New England journal of medicine.
[17] Maddocks Ac. Letter: Sterilisation of cardiac bioptome. , 1974 .
[18] D. Thelle,et al. THE TROMSØHEART-STUDY HIGH-DENSITY LIPOPROTEIN AND CORONARY HEART-DISEASE: A PROSPECTIVE CASE-CONTROL STUDY , 1977, The Lancet.
[19] H. Prydz,et al. Studies on tissue thromboplastin: I. Solubilization with sodium deoxycholate , 1966 .
[20] L. Carlson,et al. Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study. , 2009, Acta medica Scandinavica.
[21] M. Blombäck,et al. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. , 1985, The New England journal of medicine.
[22] J. N. Morris,et al. ATHEROSCLEROSIS AND CORONARY (ISCHÆMIC) HEART-DISEASE , 1961 .
[23] I. Hjermann,et al. A novel form of factor VII in plasma from men at risk for cardiovascular disease , 1985, British journal of haematology.
[24] S. Thompson,et al. HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDY , 1980, The Lancet.
[25] S. Thompson,et al. Assay of factor VII activity by two techniques: evidence for increased conversion of VII to αVIIa in hyperlipidaemia, with possible implications for ischaemic heart disease , 1985, British journal of haematology.